Identifying response and predictive biomarkers for Transcranial magnetic stimulation outcomes: protocol and rationale for a mechanistic study of functional neuroimaging and behavioral biomarkers in veterans with Pharmacoresistant depression

BACKGROUND: Although repetitive transcranial magnetic stimulation (‘TMS’) is becoming a gold standard treatment for pharmacoresistant depression, we lack neural target biomarkers for identifying who is most likely to respond to TMS and why. To address this gap in knowledge we evaluate neural targets...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, Leanne M., Coman, John T., Stetz, Patrick C., Walker, Nicole C., Kozel, F. Andrew, George, Mark S., Yoon, Jong, Hack, Laura M., Madore, Michelle R., Lim, Kelvin O., Philip, Noah S., Holtzheimer, Paul E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7805238/
https://www.ncbi.nlm.nih.gov/pubmed/33435926
http://dx.doi.org/10.1186/s12888-020-03030-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7805238/
https://www.ncbi.nlm.nih.gov/pubmed/33435926
http://dx.doi.org/10.1186/s12888-020-03030-z

Ejemplares similares